Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Sept 2026 for Definium Therapeutics, Inc., €1.0M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert B Barrow: trading record in brief
Robert B Barrow is a declared insider of Definium Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 25 June 2026 to 25 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 25 September 2026, reports a transaction of €1.0M in Definium Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert B Barrow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
31,550 shares@ US$36.73CommonSEC144:0001950047-26-009813
19,023 shares@ US$37.75140.013% mcap36.4% of flowCommonSEC144:0001950047-26-009064
29,208 shares@ US$42.13100.0% of flowCommonSEC144:0001950047-26-006487
3 of 3 declarations
